Literature DB >> 19895980

The irreversible component of persistent asthma.

Rodolfo M Pascual1, Stephen P Peters.   

Abstract

Irreversible airflow obstruction or limitation occurs in some patients with asthma, can develop early in life, and becomes more common as asthma becomes more severe. Efforts to understand irreversible airflow obstruction or limitation have been hampered by the lack of a standardized definition of the phenotype and by the lack of appropriate research models. Unfortunately, it appears that currently available asthma treatments do not prevent this important asthma complication. Herein, the evidence of an irreversible component of asthma, its underlying pathology, and the limitations of current asthma treatments are reviewed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895980      PMCID: PMC4283201          DOI: 10.1016/j.jaci.2009.09.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  94 in total

Review 1.  The Melbourne Asthma Study: 1964-1999.

Authors:  Peter D Phelan; Colin F Robertson; Anthony Olinsky
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

Review 2.  Systems biology in drug discovery.

Authors:  Eugene C Butcher; Ellen L Berg; Eric J Kunkel
Journal:  Nat Biotechnol       Date:  2004-10       Impact factor: 54.908

3.  Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.

Authors:  Aaron Deykin; Michael E Wechsler; Homer A Boushey; Vernon M Chinchilli; Susan J Kunselman; Timothy J Craig; Emily DiMango; John V Fahy; Monica Kraft; Frank Leone; Stephen C Lazarus; Robert F Lemanske; Richard J Martin; Gene R Pesola; Stephen P Peters; Christine A Sorkness; Stanley J Szefler; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

4.  Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction.

Authors:  Marta Kaminska; Susan Foley; Karim Maghni; Claudine Storness-Bliss; Harvey Coxson; Heberto Ghezzo; Catherine Lemière; Ronald Olivenstein; Pierre Ernst; Qutayba Hamid; James Martin
Journal:  J Allergy Clin Immunol       Date:  2009-05-29       Impact factor: 10.793

5.  T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma.

Authors:  Wisam Al-Ramli; David Préfontaine; Fazila Chouiali; James G Martin; Ron Olivenstein; Catherine Lemière; Qutayba Hamid
Journal:  J Allergy Clin Immunol       Date:  2009-04-10       Impact factor: 10.793

6.  Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma.

Authors:  Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern
Journal:  Mucosal Immunol       Date:  2009-08-26       Impact factor: 7.313

7.  Intermittent inhaled corticosteroids in infants with episodic wheezing.

Authors:  Hans Bisgaard; Mette Northman Hermansen; Lotte Loland; Liselotte Brydensholt Halkjaer; Frederik Buchvald
Journal:  N Engl J Med       Date:  2006-05-11       Impact factor: 91.245

8.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.

Authors:  C Ward; M Pais; R Bish; D Reid; B Feltis; D Johns; E H Walters
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

9.  Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma.

Authors:  Bradley E Chipps; Stanley J Szefler; F Estelle R Simons; Tmirah Haselkorn; David R Mink; Yamo Deniz; June H Lee
Journal:  J Allergy Clin Immunol       Date:  2007-03-30       Impact factor: 10.793

Review 10.  Natural history of asthma: persistence versus progression-does the beginning predict the end?

Authors:  Reynold A Panettieri; Ronina Covar; Evalyn Grant; Elizabeth V Hillyer; Leonard Bacharier
Journal:  J Allergy Clin Immunol       Date:  2008-03       Impact factor: 10.793

View more
  11 in total

Review 1.  Pathogenetic and prognostic roles of bloodborne fibrocytes in asthma.

Authors:  Sabrina Mattoli
Journal:  J Zhejiang Univ Sci B       Date:  2015-08       Impact factor: 3.066

2.  Pulmonary remodeling in asthma.

Authors:  Phil Lieberman
Journal:  F1000 Med Rep       Date:  2010-10-12

3.  Endothelin-1 directs airway remodeling and hyper-reactivity in a murine asthma model.

Authors:  L G Gregory; C P Jones; S A Mathie; S Pegorier; C M Lloyd
Journal:  Allergy       Date:  2013-10-14       Impact factor: 13.146

4.  Inhibition of airway remodeling and inflammatory response by Icariin in asthma.

Authors:  Lingli Hu; Lulu Li; Hongying Zhang; Qiuping Li; Shan Jiang; Jian Qiu; Jing Sun; Jingcheng Dong
Journal:  BMC Complement Altern Med       Date:  2019-11-19       Impact factor: 3.659

5.  Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite.

Authors:  Zhuang-Gui Chen; Tian-Tuo Zhang; Hong-Tao Li; Fen-Hua Chen; Xiao-Ling Zou; Jing-Zhi Ji; Hong Chen
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

6.  [Factors associated with a severe asthma in asthmatic patients followed at Pneumo-phthisiology National Hospital of Cotonou (Benin) in 2014].

Authors:  Bella Adodo Hounkpe-Dos Santos; Akpa Raphaël Gbary; Alphonse Kpozehouen; Ferdinand Kassa
Journal:  Pan Afr Med J       Date:  2015-09-07

Review 7.  Refractory asthma: mechanisms, targets, and therapy.

Authors:  J L Trevor; J S Deshane
Journal:  Allergy       Date:  2014-04-29       Impact factor: 13.146

Review 8.  Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach.

Authors:  Raffaela Zaffini; Giovanni Gotte; Marta Menegazzi
Journal:  Drug Des Devel Ther       Date:  2018-02-12       Impact factor: 4.162

Review 9.  Lacticaseibacillus rhamnosus: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control.

Authors:  Moloko G Mathipa-Mdakane; Mapitsi S Thantsha
Journal:  Foods       Date:  2022-03-08

Review 10.  Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach.

Authors:  Agamemnon Bakakos; Stamatina Vogli; Katerina Dimakou; Georgios Hillas
Journal:  J Pers Med       Date:  2022-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.